IGF-1 LR3

IGF-1 LR3 0.1 mg – Research Peptide (Vial / Kit)

IGF-1 LR3 is a synthetic peptide analogue with a defined amino acid sequence and modified molecular structure. It is referenced in scientific and educational research for its stability and characteristics under controlled laboratory conditions.

This product is supplied as a 0.1 mg (100 mcg) lyophilised peptide and is intended strictly for research and educational use.

Product Details

• Peptide: IGF-1 LR3

• Quantity: 0.1 mg (100 mcg) per vial

• Format: Lyophilised powder

• Available as: Single vial or kit

• Packaging: Secure, sealed vial(s)

• Verification: QR-based product authentication included

Quality & Verification

Quality, transparency, and traceability are central to Kings Clinics’ standards. Each IGF-1 LR3 vial is:

• Tested for purity and identity

• Clearly labelled with batch and lot information

• Supplied with verification and traceability

• Handled and distributed under controlled standards

Each unit includes a unique QR-based verification system, allowing customers to confirm authenticity and batch details directly through our website.

Storage & Handling (General Guidance)

• Store in a cool, dry environment

• Protect from excessive heat, light, and moisture

• Handle in accordance with appropriate laboratory practices

Important Notice

This product is supplied for research and educational purposes only.
It is not intended for human or animal consumption, medical use, or as a dietary supplement.
No medical, therapeutic, or performance claims are made or implied.

Purchasers are responsible for ensuring compliance with all applicable local laws and regulations.